Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases
About This Trial
The goal of this cross-sectional observational study is to to perform a thorough characterization of the quantitative and qualitative differences in peripheral blood cells, and circulating factors (proteins, metabolites, lipids, extracellular vesicles) in different stages of several metabolic diseases (diabetes, obesity, non-alcoholic fatty liver disease) that share common pathophysiological mechanisms and in comparison with adult healthy controls. The main question\[s\] it aims to answer are: * Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in platelets in patients with metabolic diseases vs subjects without metabolic diseases * Which are the quantitative (number and concentration) and qualtitative (characteristics, functional assays) differences in leucocytes or circulating molecules in patients with metabolic diseases vs subjects without metabolic diseases
Who May Be Eligible (Plain English)
Original Eligibility Criteria
View original clinical language
Treatments Being Tested
Oral glucose tolerance test
75g of a standardized glucose solution followed by blood draw at 0, 30, 60, 90, 120 min
Liver Ultrasound
A crude assessment of liver status in order to identify the presence of steatosis or not will take place with ultrasound.
Fibroscan of the Liver
FibroScan non-invasively measures the stiffness of the liver by capturing and calculating the speed of a shear wave as it travels through the liver (vibration controlled transient elastography).
Magentic Resonance Imaging (MRI) of the liver
The exact calculation of liver fat with proton density fat fraction will take place with MRI.